Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents

Stevens, Hannah; McFadyen, James D.; Chan, Noel

doi:10.1055/s-0041-1723953

Cited by 3 publications

(2 citation statements)

References 141 publications

(143 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Tere has been no bibliometric analysis conducted regarding VTE anticoagulation until now. Most of the literature on VTE anticoagulation research is limited to reviews that list or summarize the existing research and lack analysis of research hotspots or development trends, failing to provide substantive suggestions to scholars [11,20]. Te present study is the frst to conduct literature bibliometric and visual analysis involving VTE anticoagulation.…”

Section: Introductionmentioning

confidence: 97%

Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021

Wang,

Liu,

Yan

et al. 2023

Journal of Interventional Cardiology

View full text Add to dashboard Cite

Background. Venous thromboembolism (VTE) is a common cardiovascular disease that seriously threatens human lives. Anticoagulant therapy is considered to be the cornerstone of VTE treatment. An increasing number of studies has been updated in the VTE anticoagulation field. However, no bibliometric analyses have assessed these publications comprehensively. Therefore, our study aimed to analyze the global status, hotspots, and trends of anticoagulant therapy for VTE. Methods. The relevant literature on VTE anticoagulation published between 2012 and 2021 was retrieved and collected from the Web of Science Core Collection database. VOSviewer, Cooccurrence Matrix Builder, gCLUTO, and some online visualization tools were adopted for bibliometric analysis. Results. A total of 15,152 related articles were retrieved. In recent years, the research output of VTE anticoagulation gradually increased. The United States was the most productive country. International cooperation is concentrated in North America and Europe; the most influential documents, journals, authors, and organizations were also from these two continents. Research hotspots mainly focus on clinical guidelines, VTE in special populations, non-vitamin K oral anticoagulants (NOACs), and parenteral anticoagulation. The research frontiers and trends include the assessment of NOACs and the antithrombotic management of VTE complicated with coronavirus disease 2019 (COVID-19). Conclusion. This bibliometric analysis provides a systematic overview of the VTE anticoagulation research, which will facilitate researchers to better understand the situation of VTE anticoagulation. Future studies should be dedicated to NOACs application and VTE-combined COVID-19 patients.

show abstract

Section: Introductionmentioning

confidence: 97%

Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021

Wang,

Liu,

Yan

et al. 2023

Journal of Interventional Cardiology

View full text Add to dashboard Cite

show abstract

“…Drug prevention is mainly the use of anticoagulant drugs, while physical prevention mainly involves applying pressure to the lower limbs to promote blood flow ( 11 , 12 ). The third is the treatment of VTE, including drug treatment and surgical treatment ( 13 ). As for the risk factors of VTE, however, there are relatively few studies examining the general population and more general risk factors.…”

Section: Introductionmentioning

confidence: 99%

Serum levels of lead are associated with venous thromboembolism: a retrospective study based on the NHANES database (1999 to 2018)

Xiao,

Li,

Wang

et al. 2023

J Thorac Dis

View full text Add to dashboard Cite

Background Venous thromboembolism (VTE) is a common clinical problem. While lead toxicity is known to affect the nervous, hematopoietic system, skeletal, and cardiovascular system, the relationship between blood lead levels and VTE remains unclear. This study explored whether there is a correlation between the levels of serum lead and VTE through a retrospective analysis based on data from the National Health and Nutrition Examination Survey (NHANES), so as to provide a reference for follow-up research and clinical practice. Methods According to the inclusion and exclusion criteria, subjects were enrolled from the NHANES (1999 to 2018) database and divided into a VTE group and a non-VTE group. The factors related to VTE were analyzed by single factor and multiple factor logistic regression analysis. Results A total of 31,081 subjects were included, of which 59 had VTE (0.19%). The higher the levels of serum lead, the higher the incidence of VTE. The univariate analysis revealed that age, male sex, history of cigarette use, hypertension, diabetes, and serum lead levels were factors associated with VTE in the population from the NHANES database. Further multivariate analysis revealed that age, history of cigarette use, hypertension, diabetes, and serum lead levels were factors associated with VTE. Conclusions The findings of this study suggest that higher serum levels of lead may be associated with VTE.

show abstract

1 Introduction

2025

Venous Thromboembolism

View full text Add to dashboard Cite

Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents

Cited by 3 publications

References 141 publications

Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021

Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge-Map Analysis from 2012 to 2021

Serum levels of lead are associated with venous thromboembolism: a retrospective study based on the NHANES database (1999 to 2018)

1 Introduction

Contact Info

Product

Resources

About